药物遗传测试 - - 证据,挑战和采用途径
Nihal El Rouby1,2, Julie A Johnson3,4
1Division of Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati.
NEJM evidence
|September 23, 2025
概括
临床药物遗传学测试使用遗传学来指导药物选择和剂量,以获得更好的患者结果. 尽管使用量增加,临床医生信任,报销和指导方针整合方面的挑战仍然存在,未来有机会进行更广泛的测试和电子健康记录整合.
科学领域:
- 药物基因组学和精准医学
- 临床药理学 临床药理学
- 遗传学和药物反应
背景情况:
- 遗传学显著影响个人对药物的反应.
- 临床药物遗传测试越来越多地用于个性化药物治疗.
- 在各种医疗专业中,已经确定了许多药物遗传学关联.
研究的目的:
- 审查临床药物遗传学的现状.
- 识别促进者和阻碍其采用的障碍.
- 概述未来扩大其使用的机会.
主要方法:
- 审查最近的科学文献和临床实践趋势.
- 对影响药物遗传学在医疗保健中的整合因素的分析.
- 确定挑战和未来的方向.
主要成果:
- 药物遗传测试的普及和公众兴趣有所增加.
- 关键的挑战包括临床医生的信心,报销,数据要求和指导方针的纳入.
- 有机会进行多基因小组,临床医师培训,电子健康记录集成和结果数据.
结论:
- 临床药物遗传学为优化药物治疗提供了显著的潜力.
- 解决目前的障碍对于更广泛的实施至关重要.
- 未来的进步很可能涉及技术整合和证据生成.
更多相关视频
相关概念视频
Analysis of Population Pharmacokinetic Data
682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
Measurement of Bioavailability: Pharmacodynamic Methods
236
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
236
Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Dosage Regimens: Partial Pharmacokinetic Parameters
155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155
Human Genetics
1.5K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.5K
Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166


